Wednesday, 17 June 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 17 June 2026
News

Aussie pharma class action boom

Posted 17 June 2026 AM

Four out of five health and life sciences leaders expect litigation in Australia to increase, and not everyone is prepared for it.

The Strategic Risk Signals: How life sciences leaders stay ahead of disputes in Australia report released by law firm MinterEllison highlights how mass-tort litigation that has succeeded in the United States has repeatedly migrated to Australia, in some cases leading to payouts in the hundreds of millions of dollars - and life science organisations in Australia need to take the pattern seriously.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (24)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.